Use este identificador para citar ou linkar para este item: http://www.repositorio.ufop.br/jspui/handle/123456789/10982
Registro completo de metadados
Campo Dublin CoreValorIdioma
dc.contributor.authorCaldas, Ivo Santana-
dc.contributor.authorMenezes, Ana Paula de Jesus-
dc.contributor.authorDiniz, Lívia de Figueiredo-
dc.contributor.authorNascimento, Alvaro Fernando da Silva do-
dc.contributor.authorNovaes, Rômulo Dias-
dc.contributor.authorCaldas, Sérgio-
dc.contributor.authorBahia, Maria Terezinha-
dc.date.accessioned2019-04-09T15:00:39Z-
dc.date.available2019-04-09T15:00:39Z-
dc.date.issued2019-
dc.identifier.citationCALDAS, I. S. et al. Parasitaemia and parasitic load are limited targets of the aetiological treatment to control the progression of cardiac fibrosis and chronic cardiomyopathy in Trypanosoma cruzi-infected dogs. Acta Tropica, v. 189, p. 30-38, jan. 2019. Disponível em: <https://www.sciencedirect.com/science/article/pii/S0001706X18304637?via%3Dihub>. Acesso em: 25 fev. 2019.pt_BR
dc.identifier.issn0001706X-
dc.identifier.urihttp://www.repositorio.ufop.br/handle/123456789/10982-
dc.description.abstractIt is still unclear whether the progression of acute to chronic Chagas cardiomyopathy is predominantly associated with the limited efficacy of aetiological chemotherapy, or with the pharmacological resistance profiles and pathogenicity of specific Trypanosoma cruzi strains. Thus, we tested the hypothesis that parasitic load could be a limited target of aetiological chemotherapy to prevent chronic cardiomyopathy in dogs infected by different T. cruzi strains. Animals were infected with benznidazole-susceptible (Berenice-78) and -resistant (VL-10 and AAS) strains of T. cruzi. A quantitative real-time PCR strategy was developed to comparatively quantify the parasite load of the three different strains using a single standard curve. For dogs infected with the VL-10 strain, benznidazole treatment reduced cardiac parasitism during the acute phase of infection. However, similar parasite load and collagen deposition were detected in the myocardium of treated and untreated animals in the chronic phase of the infection. In animals infected with the AAS strain, benznidazole reduced parasite load, myocarditis and type III collagen deposition in the acute phase. However, increased type III collagen deposition was verified in the chronic phase. Dogs infected with the Berenice-78 strain showed a parasitological cure and no evidence of myocardial fibrosis. Parasitic load and cardiac fibrosis presented no correlation in acute or chronic phases of T. cruzi infection. Our findings in a canine model of Chagas disease suggest that parasite burden is a limited predictor for disease progression after treatment and show that benznidazole, although not inducing parasitological cure, is able to prevent total fibrosis in the early stages of infection, as well as complete prevention of cardiac damage when it eliminates parasites at the onset of infection.pt_BR
dc.language.isoen_USpt_BR
dc.rightsrestritopt_BR
dc.subjectCardiovascular pathologypt_BR
dc.subjectExperimental chemotherapypt_BR
dc.subjectChagas diseasept_BR
dc.titleParasitaemia and parasitic load are limited targets of the aetiological treatment to control the progression of cardiac fibrosis and chronic cardiomyopathy in Trypanosoma cruzi-infected dogs.pt_BR
dc.typeArtigo publicado em periodicopt_BR
dc.identifier.uri2https://www.sciencedirect.com/science/article/pii/S0001706X18304637pt_BR
Aparece nas coleções:DECBI - Artigos publicados em periódicos

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
ARTIGO_ParasitaemiaParasiticLoad.pdf
  Restricted Access
2,19 MBAdobe PDFVisualizar/Abrir


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.